Re: Bisphosphonates

Alexander Vasserman DDS wrote:

Another problem is there are still many dentists and md's in practice
who are not even aware of the risks of doing surgical procedures on
patients who are taking bisphosphonates.
The FDA or state boards have not even made an effort to contact health
care professionals.
I found out about this problem through word of mouth then had to do my
own research.
Later we saw articles on this from the dental associations however
solutions as to how to proceed weren't clear until very recently.

Well, IMO they're still far from clear. :-/.
I used to get an FDA newsletter with reports of adverse reactions--they either stopped mailing them or I got off the mailing list.
I did receive a mailing from Novartis a couple of years ago.
I have no idea how many docs are unaware of the problem at this late date (I don't doubt that there are some), but the bigger problem is the patient who doesn't note it in the medical history.

Steve


us wrote:

In article <OIWdnZt9Y5DdN_XYnZ2dnUVZ_vKdnZ2d@xxxxxxxxxxx>,
fritzfield@xxxxxxxxxxx says...

Anyone have any horror stories about the ubiquitous oral bisphosphonates
(Boniva, Fosamax)causing osteonecrosis of the jaw as a result of perio
surg, implants, or extraction?


I have been researching this on the web and have found plenty of
reassuring statistics such as "Less than 1 chance in 100000", etc.

However, that does not seem to be the correct question and answer.

What I think needs to be identified is, for a given population of
Fosamax users who have tooth extractions, implants, or other invasive
dental procedures, what percentage experiences ONJ?

So:

1. Among those of you who are on therapy now, who among you have had
extractions, implants, etc?

2. For those of you are dentists and oral health professionals, have you
performedthese operations on patients who are on oral fosamax therapy,
and what sorts of results have you seen?

Thanks for any replies.

Just me




--
Mark & Steven Bornfeld DDS
http://www.dentaltwins.com
Brooklyn, NY
718-258-5001
.

Relevant Pages

  • Re: FDA reversal OKs morphine painkiller for dying
    ... on the local ER for treatment of a cancer patients pain? ... "A liquid morphine painkiller given by family ... One doctors group had told the FDA that last week's order would "cause ...
    (alt.support.chronic-pain)
  • Re: FDA to take "unprecedented" action Re: pain meds
    ... They're going to drive any doctors even remotely close to retirement to do ... misuse of prescription painkillers, under pressure from regulators trying to ... The FDA sent letters to 16 companies in February ordering them to design ... access to patients. ...
    (alt.support.chronic-pain)
  • Re: Trovan and liver TOXICITY
    ... What action is FDA announcing today? ... The treating physician believes that, given the new safety information, ... What are the problems occurring with the use of Trovan? ... FDA began receiving reports of patients who experienced serious ...
    (sci.med.diseases.lyme)
  • FDA: Trovan and liver toxicity
    ... What action is FDA announcing today? ... What are the problems occurring with the use of Trovan? ... FDA began receiving reports of patients who experienced serious ... liver reactions in association with use of the product. ...
    (sci.med.diseases.lyme)
  • FDA official - If MS drug back on market, some patients could die
    ... FDA official - If MS drug back on market, ... WASHINGTON - Dozens of multiple sclerosis patients asked federal health ... said the risk of MS was greater than that of Tysabri. ... FDA was expected late Wednesday. ...
    (alt.support.mult-sclerosis)